Detalhe da pesquisa
1.
Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease.
Blood Adv
; 7(6): 943-952, 2023 03 28.
Artigo
Inglês
| MEDLINE | ID: mdl-36355805